CLNN
Clene Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.35
+4.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.91x
- P/S forward
- 244.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.47x
- Price / sales
- 310.64x
- Price / cash flow
- -3.84x
Enterprise value
- Enterprise value
- $73.9M
- EV / sales
- 374.97x
- EV / EBITDA
- -2.66x
- EV / EBIT
- -3.64x
- Market cap
- $61.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026